Banks leading Anthropic's initial public offering have begun scheduling meetings between the company's executives and prospective institutional investors, marking the formal opening stage of the roadshow process, according to new reporting. Roadshow investor meetings typically precede a public listing by four to eight weeks, putting Anthropic's rumored October 2026 Nasdaq debut squarely within reach if the timeline holds from here.
Anthropic confidentially filed its S-1 registration statement with the SEC on June 1, and Goldman Sachs and Morgan Stanley are leading the offering with JPMorgan also involved. The company's most recent private valuation stands at $965 billion, set during its $65 billion Series H-1 round in May -- a figure the roadshow meetings now beginning will need to actively defend to institutional investors who haven't had the benefit of Anthropic's rapid private markups to anchor their own view of fair value.
The competitive framing matters as much as the mechanics: OpenAI, Anthropic's chief rival, has pushed its own IPO target from fall 2026 into 2027, meaning Anthropic reaching the investor-meeting stage now widens its lead in the race to become the first major AI-safety-focused lab to actually price a public offering. Being first sets the valuation and disclosure benchmark every subsequent AI lab IPO gets measured against, a real strategic prize independent of Anthropic's own listing outcome.
The roadshow arrives with a complicating precedent already on the tape: SpaceX, the only comparable mega-cap tech IPO this year, popped more than 37% in its first week before sliding to trade roughly 39% below that peak. Anthropic's investor meetings will need to make a convincing case -- likely centered on its reported jump to a $47 billion revenue run rate by May, up from $9 billion at the end of 2025 -- that its growth is durable enough to avoid a similar post-IPO round trip.
What to watch: how institutional investors react in these early roadshow meetings, which will shape final pricing, and whether Anthropic holds its October target given typical SEC review timelines for a filing this size.